sec filing
DM
NASDAQ · DMII
Drugs Made In America Acquisition II Corp. Ordinary Shares
Financial Services · Shell Companies
$10.21
Up+$0.00 (+0.00%)
Updated Nov 4, 2026, 6:34 AM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 518.58M
- P/E ratio
- -54.87
- Dividend yield
- 0.00%
- 52-week range
- $9.94 – $10.33
- Volume
- 9.18K
- Avg. volume
- 429.72K
Price performance · DMII
DMII price history
1M range · 19 trading sessions · Daily adjusted prices
Prices through Nov 3, 2026
DMII closed at $10.21 after 19 trading sessions, up 0.25% for the selected period.
- Last close
- $10.21
- Period change
- +0.25%
- Period low
- $10.18
- Period high
- $10.21
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 3, 2026 | $10.21 | $10.215 | $10.21 | $10.21 | 9.18K |
| Nov 2, 2026 | $10.205 | $10.21 | $10.195 | $10.21 | 24.76K |
| Oct 30, 2026 | $10.205 | $10.205 | $10.20 | $10.20 | 100.75K |
| Oct 29, 2026 | $10.20 | $10.205 | $10.19 | $10.20 | 35.39K |
| Oct 26, 2026 | $10.19 | $10.20 | $10.18 | $10.195 | 188.03K |
| Oct 23, 2026 | $10.19 | $10.19 | $10.19 | $10.19 | 277 |
| Oct 22, 2026 | $10.195 | $10.195 | $10.18 | $10.19 | 349.39K |
| Oct 21, 2026 | $10.19 | $10.20 | $10.19 | $10.19 | 411.46K |
| Oct 20, 2026 | $10.18 | $10.185 | $10.175 | $10.185 | 271.66K |
| Oct 19, 2026 | $10.19 | $10.19 | $10.17 | $10.175 | 74.14K |
| Oct 16, 2026 | $10.19 | $10.19 | $10.18 | $10.18 | 1.04M |
| Oct 15, 2026 | $10.19 | $10.19 | $10.18 | $10.19 | 121.8K |
| Oct 14, 2026 | $10.195 | $10.195 | $10.19 | $10.19 | 449.06 |
| Oct 13, 2026 | $10.19 | $10.195 | $10.19 | $10.19 | 374.46K |
| Oct 12, 2026 | $10.19 | $10.1975 | $10.19 | $10.19 | 859.45K |
| Oct 9, 2026 | $10.19 | $10.19 | $10.19 | $10.19 | 600.24K |
| Oct 8, 2026 | $10.19 | $10.19 | $10.19 | $10.19 | 250.24K |
| Oct 7, 2026 | $10.20 | $10.20 | $10.18 | $10.19 | 119.05K |
| Oct 6, 2026 | $10.20 | $10.20 | $10.18 | $10.185 | 103.33K |
Latest DMII news
The latest Smart Investors Daily articles mentioning DMII.
Stock researchCompany · Overview
Company
Market Activity
Research & News
DMII research
Overview
Company profile and research snapshot.
Company profile
Drugs Made In America Acquisition II Corp is a blank check Company.
Analyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.